PL366009A1 - Sposoby i kompozycje do leczenia chorób zapalnych - Google Patents

Sposoby i kompozycje do leczenia chorób zapalnych

Info

Publication number
PL366009A1
PL366009A1 PL01366009A PL36600901A PL366009A1 PL 366009 A1 PL366009 A1 PL 366009A1 PL 01366009 A PL01366009 A PL 01366009A PL 36600901 A PL36600901 A PL 36600901A PL 366009 A1 PL366009 A1 PL 366009A1
Authority
PL
Poland
Prior art keywords
compositions
treatment
methods
inflammatory diseases
inflammatory
Prior art date
Application number
PL01366009A
Other languages
English (en)
Inventor
Sivaram Pillarisetti
Uday Saxena
Angela Vines
Shianlen Cahoon
Original Assignee
Reddy Us Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy Us Therapeutics, Inc. filed Critical Reddy Us Therapeutics, Inc.
Publication of PL366009A1 publication Critical patent/PL366009A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/9121Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL01366009A 2000-10-02 2001-10-02 Sposoby i kompozycje do leczenia chorób zapalnych PL366009A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23714700P 2000-10-02 2000-10-02

Publications (1)

Publication Number Publication Date
PL366009A1 true PL366009A1 (pl) 2005-01-24

Family

ID=22892514

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366009A PL366009A1 (pl) 2000-10-02 2001-10-02 Sposoby i kompozycje do leczenia chorób zapalnych

Country Status (10)

Country Link
US (1) US6900041B2 (pl)
EP (1) EP1334207A2 (pl)
AU (1) AU2001296959A1 (pl)
BR (1) BR0114411A (pl)
CA (1) CA2424246A1 (pl)
EA (1) EA200300442A1 (pl)
IL (1) IL155174A0 (pl)
MX (1) MXPA03002916A (pl)
PL (1) PL366009A1 (pl)
WO (1) WO2002029091A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366250A1 (pl) * 2000-12-29 2005-01-24 Reddy Us Therapeutics, Inc. Sposoby i kompozycje do wykrywania związków modulujących odpowiedzi zapalne
US7363569B2 (en) 2001-06-29 2008-04-22 Intel Corporation Correcting for data losses with feedback and response
US7231653B2 (en) 2001-09-24 2007-06-12 Intel Corporation Method for delivering transport stream data
US20050118564A1 (en) * 2002-01-31 2005-06-02 Sivaram Pillarisetti Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases
EP1575513A4 (en) * 2002-08-16 2007-04-04 Wyeth Corp COMPOSITIONS AND METHODS FOR TREATING RAGE-ASSOCIATED DISEASES
GEP20105110B (en) * 2004-08-03 2010-11-10 Transtech Pharma Inc Rage fusion proteins and their use
SG161242A1 (en) * 2004-08-03 2010-05-27 Transtech Pharma Inc Rage fusion proteins and methods of use
EP1749523A1 (en) 2005-07-29 2007-02-07 Neuropharma, S.A. GSK-3 inhibitors
JP5314428B2 (ja) * 2005-12-23 2013-10-16 ジーコデール システムズ アクチボラゲット 測位用パターン
EP1989227A2 (en) * 2006-02-09 2008-11-12 Transtech Pharma, Inc. Rage fusion proteins and methods of use
SG171670A1 (en) * 2006-05-05 2011-06-29 Transtech Pharma Inc Rage fusion proteins, formulations, and methods of use thereof
WO2008100470A2 (en) * 2007-02-15 2008-08-21 Transtech Pharma, Inc. Rage - immunoglobulin fusion proteins
KR101595634B1 (ko) * 2007-06-14 2016-02-18 갈락티카 파마슈티칼스, 인크. Rage 융합 단백질
AU2010240569A1 (en) 2009-04-20 2011-10-20 Pfizer Inc. Control of protein glycosylation and compositions and methods relating thereto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
GB9828640D0 (en) * 1998-12-23 1999-02-17 Smithkline Beecham Plc Novel method and compounds
AU2337601A (en) * 1999-12-23 2001-07-09 Ontario Cancer Institute, The Inhibition of gsk-3beta
CA2417277A1 (en) * 2000-07-27 2002-02-07 F. Hoffmann-La Roche Ag 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta.
PL366250A1 (pl) * 2000-12-29 2005-01-24 Reddy Us Therapeutics, Inc. Sposoby i kompozycje do wykrywania związków modulujących odpowiedzi zapalne

Also Published As

Publication number Publication date
EA200300442A1 (ru) 2003-10-30
US20020077293A1 (en) 2002-06-20
US6900041B2 (en) 2005-05-31
IL155174A0 (en) 2003-10-31
BR0114411A (pt) 2006-05-09
WO2002029091A2 (en) 2002-04-11
EP1334207A2 (en) 2003-08-13
AU2001296959A1 (en) 2002-04-15
WO2002029091A3 (en) 2003-05-30
MXPA03002916A (es) 2004-12-03
CA2424246A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
PL362711A1 (pl) Pochodne morfolinoacetamidu do leczenia chorób zapalnych
AU6147401A (en) Compositions and methods for the treatment of cancer
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AU2002352726A8 (en) Formulations and methods for treatment or amelioration of inflammatory conditions
AU6118001A (en) Combination therapeutic compositions and methods of use
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
PL371281A1 (pl) Sposoby i kompozycje do leczenia chorób oczu
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
EP1416795A4 (en) COMPOSITIONS AND METHODS OF TREATING DISEASES OF MITOCHONDRIA
PL368035A1 (pl) Kompozycje i sposoby leczenia raka
AU2001267404A1 (en) Novel compounds for the treatment of inflammatory and cardiovascular diseases
EP1472273A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
IL155769A0 (en) Method for the treatment of inflammation
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
EP1315499A4 (en) COMPOSITIONS AND METHODS OF TREATING ANORCAL DISEASES